About Avicenna Biosciences
Avicenna Biosciences is a company based in Durham (United States) founded in 2020. Avicenna Biosciences has raised $5.5 million across 3 funding rounds.
- Headquarter Durham, United States
-
Sectors
Technology
-
Phone
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.5 M (USD)
in 3 rounds
-
Latest Funding Round
$6 M (USD), Debt – Conventional
Nov 03, 2023
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Avicenna Biosciences
Avicenna Biosciences has successfully raised a total of $5.5M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $6 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Avicenna Biosciences
Investment portfolio details for Avicenna Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Avicenna Biosciences
Detailed financials for Avicenna Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Avicenna Biosciences Comparisons
Peer comparison for Avicenna Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Avicenna Biosciences
Detailed competitors of Avicenna Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Avicenna Biosciences
Complete news archive for Avicenna Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avicenna Biosciences
Avicenna Biosciences was founded in 2020.
Avicenna Biosciences is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Thomas Kaiser is the current CEO of Avicenna Biosciences.
Avicenna Biosciences is a funded company, having raised a total of $5.5M across 3 funding rounds to date.
Avicenna Biosciences was founded in 2020 and is based in Durham, United States. Operations focus on the biotechnology sector, where small molecule drug candidates are optimized through machine learning-enhanced medicinal chemistry. This approach is applied to accelerate the drug development process. Services target improvements in efficiency for pharmaceutical research and development.